Latest News

Market Exclusive Biotech News & Analysis

AbbVie Inc. (NYSE:ABBV): CHMP Okays Humira As Treatment For Uveitis

The European Committee for Medicinal Products for human use has approved AbbVie Inc. (NYSE:ABBV) Humira for the treatment of chronic non-infectious anterior uveitis in pediatric...

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) Turns To Layoffs In Israel...

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is planning to lay off some of its 7,000-strong staff as part of a cost-saving drive that also...